<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="species">human</item><item key="factors"><item><item key="GSM993410"><item key="TREATMENT">TNF (10ng/mL)+IL-17 (200ng/mL)</item><item key="TIME">48 hour cyotkine treatment</item></item></item><item><item key="GSM993409"><item key="TREATMENT">TNF (10ng/mL)+IL-17 (20ng/mL)</item><item key="TIME">48 hour cyotkine treatment</item></item></item><item><item key="GSM993408"><item key="TREATMENT">IL-17 (200ng/mL)</item><item key="TIME">48 hour cyotkine treatment</item></item></item><item><item key="GSM993407"><item key="TREATMENT">IL-17 (20ng/mL)</item><item key="TIME">48 hour cyotkine treatment</item></item></item><item><item key="GSM993406"><item key="TREATMENT">TNF (10ng/mL)</item><item key="TIME">48 hour cyotkine treatment</item></item></item><item><item key="GSM993405"><item key="TREATMENT">Ctrl</item><item key="TIME">48 hour cyotkine treatment</item></item></item><item><item key="GSM993404"><item key="TREATMENT">TNF (10ng/mL)+IL-17 (200ng/mL)</item><item key="TIME">24 hour cytokine treatment</item></item></item><item><item key="GSM993403"><item key="TREATMENT">TNF (10ng/mL)+IL-17 (20ng/mL)</item><item key="TIME">24 hour cytokine treatment</item></item></item><item><item key="GSM993402"><item key="TREATMENT">IL-17 (200ng/mL)</item><item key="TIME">24 hour cytokine treatment</item></item></item><item><item key="GSM99340"><item key="TREATMENT">IL-17 (20ng/mL)</item><item key="TIME">24 hour cytokine treatment</item></item></item><item><item key="GSM993400"><item key="TREATMENT">TNF (10ng/mL)</item><item key="TIME">24 hour cytokine treatment</item></item></item><item><item key="GSM993399"><item key="TREATMENT">Ctrl</item><item key="TIME">24 hour cytokine treatment</item></item></item></item><item key="id">2397</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">4</item><item key="summary_wrapped">In this study, we sought to determine how IL-17 and TNF influence normal human melanocytes,  either alone, or with both cytokines...</item><item key="geo_gse_id">E-GEOD-40413</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">2</item><item key="sample_count">12</item><item key="tags"><item>line</item><item>melanocyte</item><item>serum</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">il-17-and-tnf-synergistically-induce-growth-associ</item><item key="geo_id_plat">E-GEOD-40413_A-AFFY-44</item><item key="name">IL-17 and TNF synergistically induce growth-associated cytokines in melanocytes while suppressing melanogenesis</item><item key="created">Jul.12, 2014</item><item key="summary">In this study, we sought to determine how IL-17 and TNF influence normal human melanocytes,  either alone, or with both cytokines together. We reveal a dichotomous effect of IL-17 and TNF, which not only elicit essential mitogenic cytokines but also suppress melanogenesis by down-regulating genes of melanogenesis pathway Comparison of one batch of primary human melanocyte line cultured in serum free media, treated with TNF and/or IL-17, for either 24 or 48 hours.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-40413</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-40413/samples/</item></data></biogps>
